ArticleOncogene2026

Correction: Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide.

Junhong Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.